Organigram Global (OGI) Total Liabilities (2018 - 2026)
Organigram Global (OGI) posted quarterly Total Liabilities of $109.0 million for Q1 2026, down 5.7% on a QoQ basis from $115.6 million in Q4 2025.
Organigram Global (OGI) Total Liabilities (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Total Liabilities for 9 consecutive years, with $109.0 million the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities changed N/A year-over-year to $109.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.0 million (changed N/A YoY) and the FY2025 annual result came in at $115.6 million, changed N/A from the prior year.
- Total Liabilities eased to $109.0 million in Q1 2026 per OGI's latest filing, from $115.6 million in the prior quarter.
- Over the last five years, Total Liabilities for OGI reached as high as $154.8 million in Q3 2025 and fell as low as $20.0 million in Q3 2023.
- A 5-year average of $88.0 million and a median of $91.8 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities retreated 10.19% — and 2024, when it surged 273.11%.
- Year by year, Total Liabilities stood at $53.6 million in 2022, then sank by 62.67% to $20.0 million in 2023, then jumped by 273.11% to $74.7 million in 2024, then surged by 54.81% to $115.6 million in 2025, then decreased by 5.7% to $109.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $109.0 million, $115.6 million, and $154.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 109.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.02 Mn |
| Dec 31, 2025 | 115.61 Mn |
| Sep 30, 2025 | 154.83 Mn |
| Sep 30, 2024 | 74.68 Mn |
| Sep 30, 2023 | 20.01 Mn |
| Aug 31, 2022 | 53.62 Mn |
| Aug 31, 2021 | 59.70 Mn |
| Feb 28, 2021 | 125.54 Mn |
| Nov 30, 2020 | 154.72 Mn |
| Aug 31, 2020 | 100.91 Mn |
| May 31, 2020 | 81.18 Mn |
| Feb 29, 2020 | 124.18 Mn |
| Aug 31, 2019 | 76.79 Mn |
| May 31, 2019 | 91.61 Mn |
| Aug 31, 2018 | 90.10 Mn |